Headline News

 

Sanofi to invest in a leading-edge production site in Singapore and strengthen its vaccines manufacturing capacities

Posted on April 13, 2021

Sanofi Acquires Tidal Therapeutics, Adding Innovative mRNA-based Research Platform With Applications

Posted on April 13, 2021

Moderna Highlights Publication of Antibody Persistence Data of its COVID-19 Vaccine out to 6 Months

Posted on April 13, 2021

AstraZeneca accelerates early oncology pipeline across key strategic scientific platforms at AACR

Posted on April 13, 2021

Neoadjuvant Opdivo Plus Chemotherapy Significantly Improves Pathologic Complete Response in Patients with Resectable Non-Small Cell Lung Cancer in Phase 3 CheckMate -816 Trial

Posted on April 13, 2021

BMS Announces Opdivo plus Chemotherapy and Opdivo plus Yervoy Demonstrate Superior Survival Benefit Compared to Chemotherapy in Unresectable Advanced or Metastatic Esophageal Squamous Cell Carcinoma

Posted on April 13, 2021

Trodelvy®, Approved by FDA for the First Treatment for Metastatic Triple-Negative Breast Cancer Shown to Improve Progression-Free Survival and Overall Survival

Posted on April 13, 2021

Marketing of First Device that Uses Artificial Intelligence Authorised by FDA to Help Detect Potential Signs of Colon Cancer

Posted on April 13, 2021

Dr Anne Beal announce by GSK to join the Board as Non-Executive Director

Posted on April 13, 2021

Lilly Modified COVID-19 Purchase Agreement for bamlanivimab Alone With the U.S. Government

Posted on April 13, 2021

Kite Submits Supplemental Biologics License Application to U.S. FDA for Tecartus® in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

Posted on April 06, 2021

EYLEA® Injection Reduced Vision-threatening Complications by 68%

Posted on April 06, 2021

Sarclisa® in combination with carfilzomib and dexamethasone has been approved by U.S FDA for patients with relapsed or refractory multiple myeloma

Posted on April 06, 2021

Sanofi to build new Canada facility to increase global availability of high-dose influenza vaccine

Posted on April 06, 2021

Moderna Provides Storage Update & Announces the U.S. FDA Approval of up to 15-Doses Per Vial of its COVID-19 Vaccine

Posted on April 06, 2021